LEFLUNOMIDE

LEFLUNOMIDE was reported 105027 times

LEFLUNOMIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 6253 0.8719
1 RHEUMATOID FACTOR NEGATIVE 151 0.8629
2 RED BLOOD CELL SEDIMENTATION RATE 219 0.7849
3 RHEUMATOID FACTOR POSITIVE 4501 0.7785
4 PEMPHIGUS 9526 0.7612
5 RHEUMATIC FEVER 3332 0.7468
6 SWOLLEN JOINT COUNT INCREASED 2379 0.7453
7 DUODENAL ULCER PERFORATION 5290 0.7106
8 C-REACTIVE PROTEIN 637 0.6872
9 DEEP VEIN THROMBOSIS POSTOPERATIVE 1375 0.6865
10 LUPUS VULGARIS 846 0.6714
11 SWOLLEN JOINT COUNT 164 0.6560
12 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 438 0.6557
13 HAND DEFORMITY 8556 0.6517
14 FACET JOINT SYNDROME 2118 0.6499
15 GRIP STRENGTH 146 0.6376
16 HEPATIC ENZYME 92 0.6174
17 C-REACTIVE PROTEIN ABNORMAL 3925 0.6113
18 GRANULOMA SKIN 496 0.6041
19 SYNOVITIS 10532 0.5835
20 MUSCULOSKELETAL DEFORMITY 136 0.5812
21 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 1325 0.5746
22 X-RAY ABNORMAL 964 0.5385
23 HYPOCHOLESTEROLAEMIA 190 0.5382
24 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1097 0.5289
25 MUSCLE INJURY 4351 0.5246
26 HELICOBACTER INFECTION 5318 0.5169
27 DISLOCATION OF VERTEBRA 1176 0.5151
28 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 3161 0.4862
29 FOLLICULITIS 5075 0.4835
30 BONE EROSION 1627 0.4596
31 RETINITIS 732 0.4234
32 JOINT LAXITY 123 0.4073
33 RHEUMATOID NODULE 1122 0.4070
34 CONTRAINDICATED PRODUCT ADMINISTERED 12068 0.3982
35 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 223 0.3975
36 GLOSSODYNIA 8886 0.3965
37 PERIPHERAL VENOUS DISEASE 1608 0.3933
38 BLOOD PARATHYROID HORMONE DECREASED 576 0.3884
39 PERICARDITIS 6489 0.3858
40 BLOOD IRON ABNORMAL 357 0.3654
41 DRUG TOLERANCE DECREASED 1023 0.3639
42 SERONEGATIVE ARTHRITIS 382 0.3333
43 ANKLE ARTHROPLASTY 120 0.3306
44 RHEUMATOID LUNG 306 0.3204
45 LOOSE BODY IN JOINT 81 0.3045
46 CENTRAL NERVOUS SYSTEM LUPUS 67 0.3004
47 INTESTINAL SEPSIS 76 0.2901
48 SYSTEMIC LUPUS ERYTHEMATOSUS 10139 0.2854
49 BREAST CANCER STAGE III 1801 0.2778
50 JOINT DESTRUCTION 428 0.2751
51 WOUND 7416 0.2650
52 GRIP STRENGTH DECREASED 2252 0.2556
53 ENTHESOPATHY 400 0.2556
54 PANNICULITIS 615 0.2539
55 ANTICIPATORY ANXIETY 69 0.2537
56 TENOSYNOVITIS 698 0.2528
57 PORPHYRIA ACUTE 353 0.2460
58 WRIST DEFORMITY 146 0.2374
59 PRESBYACUSIS 73 0.2370
60 JOINT RANGE OF MOTION DECREASED 3121 0.2325
61 RED BLOOD CELL SEDIMENTATION RATE INCREASED 2573 0.2323
62 ANKLE DEFORMITY 73 0.2274
63 DEAFNESS TRANSITORY 194 0.2272
64 IRRITABLE BOWEL SYNDROME 4874 0.2271
65 LIP DRY 2063 0.2269
66 RHEUMATOID ARTHRITIS 25571 0.2250
67 FINGER DEFORMITY 1090 0.2248
68 ONYCHOMADESIS 937 0.2230
69 NECK DEFORMITY 95 0.2140
70 BURSITIS 2572 0.2118
71 ARTHROPATHY 11238 0.2020
72 SYNOVIAL DISORDER 91 0.2000
73 ONYCHOMYCOSIS 874 0.1990
74 HYPERCHOLESTEROLAEMIA 1857 0.1921
75 WOUND INFECTION 2045 0.1866
76 OVERLAP SYNDROME 129 0.1843
77 THERAPEUTIC PRODUCT EFFECT DECREASED 8235 0.1837
78 LIVE BIRTH 1537 0.1835
79 FIBROMYALGIA 4381 0.1800
80 SOFT TISSUE SWELLING 102 0.1796
81 BLEPHAROSPASM 1103 0.1750
82 ARTHRODESIS 175 0.1719
83 DACTYLITIS 166 0.1690
84 DRUG INTOLERANCE 16075 0.1662
85 IMPAIRED HEALING 5461 0.1662
86 JOINT ANKYLOSIS 92 0.1620
87 PSORIATIC ARTHROPATHY 6310 0.1553
88 LIMB DEFORMITY 244 0.1535
89 NAIL DISORDER 1304 0.1489
90 BONE CYST 138 0.1471
91 C-REACTIVE PROTEIN DECREASED 96 0.1470
92 FOOT DEFORMITY 1612 0.1453
93 AUTOIMMUNE DISORDER 1397 0.1432
94 SYSTEMIC LUPUS ERYTHEMATOSUS RASH 114 0.1429
95 LIVER INJURY 3494 0.1422
96 BLOOD PRESSURE SYSTOLIC ABNORMAL 344 0.1390
97 HYPERMOBILITY SYNDROME 69 0.1386
98 MEAN PLATELET VOLUME DECREASED 112 0.1335
99 JOINT SWELLING 16083 0.1331
100 TENOSYNOVITIS STENOSANS 74 0.1329
101 VASCULAR ACCESS COMPLICATION 106 0.1309
102 INFUSION SITE REACTION 390 0.1304
103 LOWER RESPIRATORY TRACT INFECTION 5838 0.1282
104 BLOOD PRESSURE DIASTOLIC ABNORMAL 324 0.1273
105 C-REACTIVE PROTEIN INCREASED 4624 0.1270
106 INTERVERTEBRAL DISC SPACE NARROWING 102 0.1266
107 SCIATICA 2003 0.1255
108 HEPATIC ENZYME INCREASED 8541 0.1252
109 PULMONARY FIBROSIS 2396 0.1248
110 TREATMENT FAILURE 9998 0.1206
111 INFUSION RELATED REACTION 7998 0.1205
112 EXOSTOSIS 1100 0.1203
113 DEATH NEONATAL 165 0.1185
114 ALANINE AMINOTRANSFERASE ABNORMAL 250 0.1184
115 TYPE 2 DIABETES MELLITUS 3978 0.1180
116 ALLERGY TO CHEMICALS 147 0.1180
117 JOINT ARTHROPLASTY 209 0.1166
118 SWELLING 10697 0.1142
119 PLEURAL THICKENING 78 0.1140
120 BONE SWELLING 109 0.1126
121 OBESITY 1794 0.1125
122 PRODUCT LABEL CONFUSION 655 0.1123
123 HIP ARTHROPLASTY 1709 0.1115
124 OSTEOARTHRITIS 4565 0.1076
125 BACK INJURY 1169 0.1074
126 SKIN NECROSIS 557 0.1073
127 MATERNAL EXPOSURE TIMING UNSPECIFIED 400 0.1064
128 PUSTULAR PSORIASIS 360 0.1047
129 POLYARTHRITIS 546 0.1035
130 SOFT TISSUE DISORDER 113 0.1019
131 PLEURAL FIBROSIS 103 0.1011
132 BLOODY DISCHARGE 115 0.1006
133 KNEE ARTHROPLASTY 2114 0.1003
134 PRURITUS ALLERGIC 117 0.1003
135 TUBERCULIN TEST POSITIVE 254 0.1002
136 DISCOMFORT 6063 0.0993
137 BLISTER 5478 0.0974
138 APPARENT DEATH 348 0.0965
139 BLOOD CHOLESTEROL INCREASED 4389 0.0941
140 MEAN CELL VOLUME DECREASED 145 0.0940
141 STOMATITIS 5580 0.0919
142 SYNOVIAL CYST 424 0.0917
143 MUSCULOSKELETAL STIFFNESS 7999 0.0912
144 LUPUS-LIKE SYNDROME 824 0.0908
145 VASCULITIC RASH 70 0.0907
146 RHEUMATOID FACTOR INCREASED 100 0.0895
147 DRUG TOLERANCE 451 0.0891
148 SHOULDER ARTHROPLASTY 236 0.0875
149 GAIT INABILITY 2927 0.0875
150 COELIAC DISEASE 856 0.0872
151 LIVER FUNCTION TEST INCREASED 1865 0.0868
152 BLOOD MAGNESIUM INCREASED 78 0.0865
153 LOWER LIMB FRACTURE 1661 0.0864
154 JOINT EFFUSION 590 0.0855
155 RETINAL TOXICITY 88 0.0854
156 BUTTERFLY RASH 85 0.0838
157 INFLAMMATION 4270 0.0827
158 MEAN CELL HAEMOGLOBIN DECREASED 151 0.0824
159 NIGHT SWEATS 2649 0.0821
160 PRESCRIBED OVERDOSE 1554 0.0802
161 WALKING AID USER 528 0.0800
162 MOBILITY DECREASED 5742 0.0798
163 INTERNATIONAL NORMALISED RATIO FLUCTUATION 163 0.0787
164 MYCOTIC ALLERGY 66 0.0772
165 OSTEOSCLEROSIS 121 0.0768
166 SURGICAL FAILURE 88 0.0761
167 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3556 0.0740
168 MATERNAL EXPOSURE DURING PREGNANCY 6593 0.0739
169 ILL-DEFINED DISORDER 4453 0.0732
170 BREAST CANCER STAGE II 608 0.0730
171 ABDOMINAL DISCOMFORT 12207 0.0727
172 JOINT DISLOCATION 767 0.0725
173 JOINT NOISE 138 0.0702
174 FOOT OPERATION 347 0.0700
175 CONGENITAL ANOMALY 541 0.0698
176 INVESTIGATION ABNORMAL 100 0.0695
177 ULCER HAEMORRHAGE 460 0.0679
178 MUSCULOSKELETAL PAIN 3526 0.0672
179 JOINT STIFFNESS 1760 0.0670
180 BRONCHITIS CHRONIC 162 0.0663
181 FINE MOTOR SKILL DYSFUNCTION 192 0.0663
182 GASTROINTESTINAL DISORDER 5881 0.0656
183 DEFORMITY 599 0.0640
184 PRESCRIBED UNDERDOSE 1269 0.0635
185 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 149 0.0627
186 CHONDROPATHY 170 0.0627
187 ADVERSE REACTION 827 0.0623
188 PERIPHERAL SWELLING 9607 0.0623
189 EYE INJURY 189 0.0622
190 ALOPECIA 12125 0.0617
191 NODULE 805 0.0616
192 HEPATIC FIBROSIS 210 0.0611
193 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 143 0.0610
194 SPONDYLITIS 221 0.0607
195 EAR PAIN 1180 0.0606
196 ARTHRITIS BACTERIAL 249 0.0606
197 JUVENILE IDIOPATHIC ARTHRITIS 148 0.0605
198 CREPITATIONS 180 0.0604
199 PULMONARY TOXICITY 422 0.0596
200 RHEUMATIC DISORDER 115 0.0594
201 PNEUMONIA VIRAL 189 0.0592
202 LABILE BLOOD PRESSURE 70 0.0589
203 SPINAL COLUMN INJURY 129 0.0578
204 OSTEOPOROTIC FRACTURE 110 0.0574
205 SINUSITIS 5849 0.0570
206 RASH VESICULAR 273 0.0564
207 SPINAL STENOSIS 233 0.0564
208 SENSITIVITY TO WEATHER CHANGE 297 0.0564
209 DEMYELINATION 231 0.0563
210 DRUG ERUPTION 996 0.0561
211 HEPATIC CIRRHOSIS 1050 0.0558
212 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3960 0.0556
213 LUNG DISORDER 2721 0.0555
214 MUSCLE SPASTICITY 677 0.0550
215 ORAL MUCOSAL EXFOLIATION 81 0.0535
216 DISABILITY 1046 0.0528
217 HEPATIC ENZYME ABNORMAL 258 0.0517
218 HEPATITIS 1323 0.0517
219 HYPERSENSITIVITY 9511 0.0512
220 INFECTION 7392 0.0510
221 THYROID NEOPLASM 140 0.0507
222 WHEEZING 3009 0.0507
223 SLEEP DISORDER 3558 0.0504
224 PRERENAL FAILURE 71 0.0504
225 LIVER DISORDER 2234 0.0503
226 GENERAL PHYSICAL HEALTH DETERIORATION 5820 0.0503
227 SKIN ULCER 1288 0.0498
228 INTENTIONAL PRODUCT USE ISSUE 4334 0.0494
229 INJURY 3435 0.0488
230 INFLAMMATORY MARKER INCREASED 242 0.0488
231 HYPERCALCAEMIA 602 0.0487
232 TASTE DISORDER 980 0.0483
233 BASAL CELL CARCINOMA 752 0.0482
234 OSTEOPOROSIS 1959 0.0476
235 NORMAL NEWBORN 258 0.0474
236 ARTHRITIS 3729 0.0474
237 SPINAL FUSION SURGERY 191 0.0470
238 ARTHRITIS INFECTIVE 218 0.0470
239 THERAPY NON-RESPONDER 2104 0.0468
240 DRUG-INDUCED LIVER INJURY 1466 0.0467
241 MUSCULOSKELETAL DISORDER 880 0.0462
242 DERMATITIS PSORIASIFORM 94 0.0460
243 GRANULOMA 159 0.0459
244 ANTINUCLEAR ANTIBODY POSITIVE 147 0.0452
245 KNEE DEFORMITY 67 0.0451
246 SARCOIDOSIS 214 0.0450
247 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 771 0.0449
248 ULCER 707 0.0444
249 EXPOSURE DURING PREGNANCY 2752 0.0442
250 HEPATOTOXICITY 969 0.0435
251 BLOOD PRESSURE SYSTOLIC INCREASED 848 0.0434
252 PULMONARY MASS 638 0.0428
253 OEDEMA 2318 0.0427
254 NEOPLASM SKIN 66 0.0425
255 LATENT TUBERCULOSIS 89 0.0425
256 BODY TEMPERATURE INCREASED 863 0.0423
257 ARTHRALGIA 17585 0.0422
258 JOINT LOCK 120 0.0422
259 ROAD TRAFFIC ACCIDENT 1754 0.0419
260 EAR INFECTION 1109 0.0416
261 SKIN PAPILLOMA 166 0.0414
262 CONTUSION 3983 0.0413
263 LUPUS NEPHRITIS 76 0.0406
264 ANKYLOSING SPONDYLITIS 535 0.0406
265 RESPIRATORY DISORDER 1211 0.0404
266 COLITIS MICROSCOPIC 191 0.0403
267 OSTEOLYSIS 82 0.0401
268 PHYSICAL DISABILITY 176 0.0398
269 SACROILIITIS 75 0.0397
270 PREGNANCY 795 0.0397
271 EPILEPSY 1193 0.0390
272 BONE DENSITY ABNORMAL 145 0.0388
273 VIRAL UPPER RESPIRATORY TRACT INFECTION 184 0.0387
274 IMMOBILE 169 0.0387
275 CARTILAGE INJURY 95 0.0385
276 WHITE BLOOD CELL COUNT ABNORMAL 244 0.0382
277 PHARYNGITIS 473 0.0381
278 NECK MASS 106 0.0374
279 NASOPHARYNGITIS 6892 0.0374
280 MONOCYTE COUNT INCREASED 134 0.0369
281 IMMUNODEFICIENCY 545 0.0365
282 TENDERNESS 380 0.0364
283 FUNCTIONAL GASTROINTESTINAL DISORDER 126 0.0364
284 INTERVERTEBRAL DISC DEGENERATION 335 0.0362
285 DIVERTICULITIS 1002 0.0361
286 BRONCHIECTASIS 243 0.0360
287 CUTANEOUS LUPUS ERYTHEMATOSUS 70 0.0360
288 NECK PAIN 1990 0.0356
289 CONDITION AGGRAVATED 10804 0.0355
290 DRY MOUTH 2882 0.0355
291 LYME DISEASE 118 0.0354
292 MYOSITIS 317 0.0353
293 WHEELCHAIR USER 157 0.0353
294 TONGUE DISORDER 255 0.0352
295 BLOOD PRESSURE DIASTOLIC INCREASED 162 0.0351
296 PRODUCT USE ISSUE 6510 0.0346
297 MOUTH ULCERATION 726 0.0344
298 BLOOD PRESSURE FLUCTUATION 817 0.0340
299 DELIRIUM 1178 0.0339
300 PAIN 20664 0.0336
301 LOSS OF EMPLOYMENT 100 0.0331
302 THERAPEUTIC RESPONSE DECREASED 1962 0.0323
303 JOINT INJURY 687 0.0321
304 EPIGASTRIC DISCOMFORT 125 0.0320
305 FOOD INTOLERANCE 117 0.0319
306 LOCALISED INFECTION 771 0.0318
307 RASH 13880 0.0318
308 RED CELL DISTRIBUTION WIDTH INCREASED 132 0.0317
309 BLOOD PRESSURE DIASTOLIC DECREASED 233 0.0315
310 HYPERTENSION 6679 0.0315
311 POSTOPERATIVE WOUND INFECTION 212 0.0314
312 IMPAIRED WORK ABILITY 666 0.0311
313 BODY TEMPERATURE DECREASED 303 0.0307
314 GASTROINTESTINAL PAIN 338 0.0307
315 GENERAL SYMPTOM 230 0.0307
316 BREATH SOUNDS ABNORMAL 151 0.0306
317 HYPOAESTHESIA 4578 0.0306
318 CONFUSIONAL STATE 4915 0.0304
319 DEAFNESS NEUROSENSORY 100 0.0304
320 OSTEOMYELITIS 549 0.0303
321 TENDONITIS 464 0.0299
322 URTICARIA 4919 0.0293
323 HEPATIC STEATOSIS 541 0.0290
324 DYSPEPSIA 2845 0.0289
325 CARPAL TUNNEL SYNDROME 403 0.0287
326 GASTROINTESTINAL TOXICITY 138 0.0287
327 INTERVERTEBRAL DISC PROTRUSION 623 0.0285
328 DRUG INEFFECTIVE 37556 0.0285
329 CUTANEOUS VASCULITIS 104 0.0285
330 WEIGHT INCREASED 6370 0.0284
331 BACK DISORDER 461 0.0283
332 FEAR OF INJECTION 202 0.0283
333 TENDON DISORDER 184 0.0282
334 PEPTIC ULCER 93 0.0280
335 INTERSTITIAL LUNG DISEASE 1352 0.0279
336 ACNE CYSTIC 82 0.0272
337 ROTATOR CUFF SYNDROME 347 0.0270
338 TOOTH INFECTION 356 0.0270
339 PAIN IN EXTREMITY 7806 0.0265
340 LIMB OPERATION 127 0.0264
341 BK VIRUS INFECTION 89 0.0264
342 ENDODONTIC PROCEDURE 66 0.0260
343 DRUG EFFECT INCOMPLETE 938 0.0258
344 SPINAL DISORDER 244 0.0257
345 INJECTION SITE HYPERSENSITIVITY 80 0.0256
346 LIVER FUNCTION TEST ABNORMAL 741 0.0255
347 MIGRAINE 2427 0.0254
348 SPINAL OSTEOARTHRITIS 223 0.0254
349 ALANINE AMINOTRANSFERASE INCREASED 1555 0.0253
350 PULMONARY THROMBOSIS 276 0.0253
351 TERMINAL STATE 167 0.0249
352 ADVERSE DRUG REACTION 2236 0.0249
353 ADVERSE EVENT 2276 0.0247
354 DERMATITIS ALLERGIC 310 0.0246
355 ADRENAL INSUFFICIENCY 296 0.0244
356 SCOLIOSIS 151 0.0244
357 SUSPECTED OFF LABEL USE 110 0.0243
358 TRIGGER FINGER 98 0.0240
359 ASPARTATE AMINOTRANSFERASE INCREASED 1266 0.0238
360 DYSLIPIDAEMIA 121 0.0238
361 BONE DISORDER 434 0.0238
362 HERPES ZOSTER 1367 0.0238
363 VASCULITIS 277 0.0238
364 RASH PRURITIC 1287 0.0237
365 CUSHINGOID 76 0.0237
366 CYST 292 0.0235
367 UPPER RESPIRATORY TRACT INFECTION 1087 0.0235
368 GAIT DISTURBANCE 4487 0.0234
369 ABDOMINAL PAIN UPPER 4788 0.0232
370 INJECTION SITE REACTION 1599 0.0232
371 SKIN REACTION 325 0.0230
372 BONE LESION 83 0.0230
373 LIMB DISCOMFORT 710 0.0229
374 SPINAL COLUMN STENOSIS 108 0.0228
375 FEMUR FRACTURE 704 0.0227
376 INTERVERTEBRAL DISC DISORDER 97 0.0227
377 POST PROCEDURAL INFECTION 184 0.0226
378 SECRETION DISCHARGE 283 0.0226
379 FOOT FRACTURE 428 0.0226
380 GASTROOESOPHAGEAL REFLUX DISEASE 1808 0.0224
381 IRON DEFICIENCY 101 0.0224
382 CYTOMEGALOVIRUS VIRAEMIA 99 0.0222
383 PLANTAR FASCIITIS 74 0.0220
384 ABSCESS LIMB 94 0.0220
385 LUNG NEOPLASM 94 0.0220
386 MUSCULOSKELETAL DISCOMFORT 377 0.0219
387 HYPERKERATOSIS 120 0.0217
388 DRUG USE DISORDER 182 0.0216
389 GASTRIC DISORDER 735 0.0214
390 LEUKOPENIA 1059 0.0212
391 POOR VENOUS ACCESS 219 0.0211
392 HYPERTRANSAMINASAEMIA 147 0.0211
393 MUSCULAR WEAKNESS 2402 0.0211
394 AMNESIA 1371 0.0211
395 PLEURISY 125 0.0210
396 OSTEOPENIA 316 0.0208
397 ENCEPHALITIS 144 0.0208
398 MENISCUS INJURY 127 0.0206
399 HAEMOGLOBIN INCREASED 94 0.0206
400 NERVE COMPRESSION 190 0.0206
401 CHRONIC SINUSITIS 77 0.0205
402 FATIGUE 15939 0.0205
403 PROTEIN URINE PRESENT 102 0.0204
404 MULTIPLE ALLERGIES 160 0.0204
405 UVEITIS 276 0.0203
406 APHTHOUS ULCER 155 0.0200
407 PNEUMONIA 6423 0.0198
408 TOOTH ABSCESS 201 0.0197
409 BRONCHITIS 1447 0.0195
410 TOOTH DISORDER 434 0.0195
411 TOOTH FRACTURE 214 0.0194
412 PLATELET COUNT INCREASED 253 0.0194
413 SKIN LACERATION 211 0.0194
414 THYROID DISORDER 299 0.0194
415 PHOTOSENSITIVITY REACTION 319 0.0193
416 ESCHERICHIA URINARY TRACT INFECTION 82 0.0193
417 WEIGHT FLUCTUATION 201 0.0192
418 PURULENT DISCHARGE 82 0.0192
419 ANAPHYLACTIC REACTION 1060 0.0192
420 HAEMORRHAGIC DIATHESIS 68 0.0191
421 IMMUNOSUPPRESSION 165 0.0187
422 EAR PRURITUS 65 0.0185
423 PULMONARY TUBERCULOSIS 79 0.0185
424 ORAL DISORDER 135 0.0184
425 SKIN INFECTION 206 0.0183
426 DIVERTICULUM 130 0.0183
427 TRANSAMINASES INCREASED 406 0.0182
428 PNEUMOCYSTIS JIROVECII PNEUMONIA 183 0.0182
429 SKIN WARM 106 0.0182
430 IRON DEFICIENCY ANAEMIA 168 0.0182
431 BLOOD CHOLESTEROL ABNORMAL 84 0.0182
432 FURUNCLE 144 0.0182
433 PYREXIA 6253 0.0181
434 RESPIRATORY TRACT CONGESTION 287 0.0180
435 ASTHMA 2037 0.0180
436 MEDICATION ERROR 999 0.0180
437 BEDRIDDEN 236 0.0179
438 PSORIASIS 2340 0.0179
439 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 304 0.0179
440 GLAUCOMA 343 0.0178
441 PARAESTHESIA 2801 0.0178
442 DYSSTASIA 519 0.0178
443 INSOMNIA 4732 0.0177
444 CANDIDA INFECTION 300 0.0177
445 SPINAL PAIN 208 0.0177
446 TENDON INJURY 66 0.0177
447 RALES 101 0.0174
448 LYMPHOMA 268 0.0173
449 MEMORY IMPAIRMENT 2371 0.0172
450 ORAL DISCOMFORT 238 0.0171
451 INJECTION SITE INFLAMMATION 85 0.0170
452 IMPAIRED GASTRIC EMPTYING 230 0.0169
453 EMPHYSEMA 170 0.0168
454 DRUG EFFECT DECREASED 902 0.0167
455 ABNORMAL LOSS OF WEIGHT 114 0.0167
456 HYPOKINESIA 242 0.0167
457 GASTRIC ULCER 315 0.0166
458 PRURITUS 6365 0.0165
459 FREQUENT BOWEL MOVEMENTS 447 0.0165
460 CATARACT OPERATION 98 0.0165
461 KIDNEY INFECTION 324 0.0165
462 LUNG INFECTION 256 0.0165
463 LABORATORY TEST ABNORMAL 486 0.0165
464 STRESS FRACTURE 88 0.0163
465 INCORRECT DOSAGE ADMINISTERED 79 0.0161
466 MALAISE 7084 0.0161
467 ORAL HERPES 315 0.0161
468 SKIN LESION 442 0.0161
469 OEDEMA PERIPHERAL 1960 0.0161
470 UROSEPSIS 147 0.0159
471 RHINITIS 128 0.0159
472 CATARACT 944 0.0158
473 DRUG SPECIFIC ANTIBODY PRESENT 103 0.0158
474 LUMBAR VERTEBRAL FRACTURE 72 0.0157
475 ENDOCARDITIS 80 0.0156
476 GINGIVITIS 84 0.0156
477 ERYSIPELAS 78 0.0155
478 CHEST PAIN 2875 0.0155
479 FEEDING DISORDER 314 0.0155
480 MASS 216 0.0154
481 SQUAMOUS CELL CARCINOMA 145 0.0154
482 DECREASED APPETITE 3571 0.0154
483 VOMITING 7173 0.0152
484 ORAL PAIN 341 0.0152
485 DUODENAL ULCER 107 0.0152
486 EYE DISORDER 498 0.0151
487 DEAFNESS 394 0.0151
488 HEADACHE 9380 0.0149
489 SPINAL OPERATION 184 0.0149
490 ORAL CANDIDIASIS 196 0.0149
491 WHITE BLOOD CELL COUNT INCREASED 571 0.0149
492 DIARRHOEA 9595 0.0148
493 COVID-19 PNEUMONIA 175 0.0148
494 ONYCHOCLASIS 102 0.0148
495 PNEUMONITIS 403 0.0148
496 TENDON RUPTURE 182 0.0147
497 HERPES VIRUS INFECTION 84 0.0146
498 SKIN PLAQUE 123 0.0146
499 HEART RATE DECREASED 511 0.0145
500 BACK PAIN 3362 0.0145
501 STAPHYLOCOCCAL SEPSIS 71 0.0144
502 PERIPHERAL VASCULAR DISORDER 74 0.0143
503 GROIN PAIN 126 0.0143
504 MUSCLE SPASMS 2616 0.0142
505 MOVEMENT DISORDER 457 0.0142
506 OFF LABEL USE 12440 0.0142
507 CELLULITIS 715 0.0142
508 PATHOLOGICAL FRACTURE 72 0.0142
509 WEIGHT DECREASED 3950 0.0141
510 DECREASED IMMUNE RESPONSIVENESS 138 0.0140
511 MATERNAL EXPOSURE BEFORE PREGNANCY 96 0.0140
512 HIP SURGERY 76 0.0140
513 DEPRESSION 3187 0.0140
514 BLOOD IRON DECREASED 166 0.0140
515 POLYNEUROPATHY 167 0.0139
516 GAMMA-GLUTAMYLTRANSFERASE INCREASED 309 0.0139
517 SKIN MASS 93 0.0139
518 ANAL ABSCESS 75 0.0139
519 INJECTION SITE IRRITATION 177 0.0139
520 STAPHYLOCOCCAL INFECTION 458 0.0139
521 ACCIDENT 165 0.0138
522 HYPOGAMMAGLOBULINAEMIA 90 0.0137
523 BLOOD ALKALINE PHOSPHATASE INCREASED 339 0.0136
524 INJECTION SITE HAEMATOMA 198 0.0136
525 ASTHENIA 5123 0.0136
526 MULTIPLE FRACTURES 223 0.0136
527 RESPIRATORY TRACT INFECTION 352 0.0135
528 IMMUNE SYSTEM DISORDER 178 0.0135
529 ANKLE FRACTURE 209 0.0135
530 RECTAL HAEMORRHAGE 579 0.0135
531 PHLEBITIS 69 0.0135
532 FRACTURE 255 0.0135
533 HAEMATOCRIT DECREASED 267 0.0135
534 DIABETES MELLITUS 1024 0.0134
535 PRODUCT USE IN UNAPPROVED INDICATION 3313 0.0134
536 HERNIA 258 0.0133
537 SPUTUM DISCOLOURED 126 0.0133
538 EYE INFECTION 150 0.0133
539 NAUSEA 10496 0.0132
540 RASH MACULO-PAPULAR 293 0.0132
541 BLOOD TEST ABNORMAL 185 0.0132
542 VITAMIN D DECREASED 111 0.0130
543 SCAB 148 0.0130
544 CYSTITIS 413 0.0130
545 LIGAMENT SPRAIN 128 0.0129
546 LIMB INJURY 351 0.0129
547 DRY EYE 643 0.0129
548 MENINGITIS 86 0.0129
549 NEPHROLITHIASIS 590 0.0129
550 OXYGEN SATURATION DECREASED 720 0.0128
551 DYSPNOEA 7251 0.0128
552 SINUS CONGESTION 173 0.0128
553 TYPE 1 DIABETES MELLITUS 77 0.0128
554 INFLUENZA 1414 0.0127
555 PHARYNGEAL OEDEMA 195 0.0127
556 GASTROENTERITIS VIRAL 228 0.0126
557 NERVE INJURY 140 0.0126
558 RENAL CYST 100 0.0126
559 BLOOD PRESSURE INCREASED 1913 0.0125
560 HYPERTENSIVE CRISIS 139 0.0125
561 GASTROINTESTINAL INFECTION 112 0.0125
562 ABDOMINAL PAIN 2892 0.0124
563 PANCREATITIS 651 0.0123
564 SINUS HEADACHE 73 0.0123
565 RESPIRATORY RATE INCREASED 108 0.0122
566 PYELONEPHRITIS 105 0.0121
567 INJECTION SITE WARMTH 249 0.0121
568 SPINAL COMPRESSION FRACTURE 100 0.0121
569 FEELING HOT 735 0.0120
570 LOCAL SWELLING 209 0.0120
571 DERMATITIS 250 0.0119
572 PRODUCTIVE COUGH 569 0.0119
573 FUNGAL INFECTION 397 0.0119
574 ABDOMINAL DISTENSION 1239 0.0119
575 STREPTOCOCCAL INFECTION 66 0.0118
576 LYMPHOEDEMA 82 0.0118
577 ECCHYMOSIS 81 0.0118
578 INJECTION SITE PRURITUS 789 0.0118
579 SKIN DISORDER 392 0.0117
580 HERPES SIMPLEX 75 0.0115
581 MOUTH HAEMORRHAGE 84 0.0114
582 VISUAL IMPAIRMENT 1418 0.0114
583 HEPATIC FUNCTION ABNORMAL 427 0.0114
584 PELVIC FRACTURE 89 0.0114
585 DENTAL CARIES 126 0.0114
586 VITAMIN D DEFICIENCY 111 0.0114
587 GASTROENTERITIS 165 0.0113
588 HYPOVOLAEMIA 66 0.0113
589 CARDIAC MURMUR 97 0.0112
590 BLOOD LACTATE DEHYDROGENASE INCREASED 177 0.0112
591 SCAR 190 0.0111
592 TOOTHACHE 198 0.0109
593 HYPOPHAGIA 278 0.0109
594 DRUG EXPOSURE DURING PREGNANCY 368 0.0108
595 RED BLOOD CELL COUNT DECREASED 309 0.0108
596 SEPTIC SHOCK 470 0.0108
597 TOOTH EXTRACTION 134 0.0108
598 NEPHROPATHY 100 0.0107
599 COLITIS ULCERATIVE 477 0.0107
600 UNDERDOSE 777 0.0106
601 LUNG INFILTRATION 94 0.0106
602 RHINORRHOEA 685 0.0106
603 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 79 0.0105
604 MUSCULOSKELETAL CHEST PAIN 162 0.0105
605 PNEUMONIA BACTERIAL 96 0.0104
606 LYMPHADENOPATHY 370 0.0104
607 MUSCLE STRAIN 89 0.0103
608 NEURALGIA 250 0.0103
609 DEEP VEIN THROMBOSIS 666 0.0102
610 PANCYTOPENIA 571 0.0102
611 BLOOD ALBUMIN DECREASED 81 0.0102
612 ATELECTASIS 98 0.0101
613 PAIN IN JAW 286 0.0101
614 PULMONARY CONGESTION 133 0.0101
615 HAEMOGLOBIN DECREASED 1034 0.0101
616 COUGH 2811 0.0100
617 ARTHROPOD BITE 74 0.0100
618 DRUG RESISTANCE 255 0.0099
619 DIZZINESS 4951 0.0099
620 INJECTION SITE DISCOLOURATION 124 0.0099
621 GALLBLADDER DISORDER 177 0.0099
622 THERAPEUTIC RESPONSE SHORTENED 326 0.0098
623 EATING DISORDER 208 0.0098
624 NASAL CONGESTION 569 0.0097
625 PATHOGEN RESISTANCE 88 0.0096
626 URINARY TRACT INFECTION 1640 0.0096
627 FALL 3190 0.0096
628 POST PROCEDURAL COMPLICATION 183 0.0095
629 SEPSIS 1060 0.0095
630 MALIGNANT MELANOMA 127 0.0095
631 HYPOTHYROIDISM 301 0.0094
632 OROPHARYNGEAL PAIN 870 0.0094
633 ABORTION INDUCED 88 0.0093
634 INJECTION SITE ERYTHEMA 1149 0.0093
635 HYSTERECTOMY 80 0.0092
636 BACTERIAL INFECTION 172 0.0092
637 FLUID RETENTION 468 0.0092
638 BLOOD CREATININE INCREASED 600 0.0092
639 INCREASED TENDENCY TO BRUISE 84 0.0091
640 CONJUNCTIVITIS 169 0.0091
641 PLEURAL EFFUSION 553 0.0091
642 HYDRONEPHROSIS 68 0.0091
643 SEASONAL ALLERGY 128 0.0090
644 HIATUS HERNIA 117 0.0090
645 BLOOD URINE PRESENT 171 0.0090
646 BONE DENSITY DECREASED 282 0.0090
647 NEOPLASM MALIGNANT 600 0.0090
648 STENT PLACEMENT 72 0.0089
649 FRUSTRATION TOLERANCE DECREASED 72 0.0089
650 EYE HAEMORRHAGE 118 0.0088
651 VIRAL INFECTION 294 0.0088
652 WHITE BLOOD CELL COUNT DECREASED 956 0.0088
653 QUALITY OF LIFE DECREASED 118 0.0088
654 BODY HEIGHT DECREASED 94 0.0088
655 MUCOSAL INFLAMMATION 230 0.0088
656 MOTOR DYSFUNCTION 89 0.0087
657 PHARYNGITIS STREPTOCOCCAL 94 0.0087
658 INJECTION SITE INDURATION 112 0.0086
659 PSEUDOMONAS INFECTION 74 0.0086
660 PULMONARY EMBOLISM 815 0.0086
661 SPINAL FRACTURE 171 0.0085
662 UPPER LIMB FRACTURE 170 0.0085
663 ARTERIAL OCCLUSIVE DISEASE 67 0.0085
664 CYTOMEGALOVIRUS INFECTION 141 0.0085
665 RENAL IMPAIRMENT 712 0.0085
666 GLOMERULAR FILTRATION RATE DECREASED 104 0.0085
667 RIB FRACTURE 174 0.0085
668 HYPOCALCAEMIA 160 0.0084
669 ERYTHEMA 1729 0.0084
670 AFFECTIVE DISORDER 66 0.0084
671 CHOLELITHIASIS 274 0.0083
672 ABSCESS 133 0.0083
673 CLOSTRIDIUM DIFFICILE INFECTION 181 0.0083
674 INJECTION SITE SWELLING 635 0.0083
675 HYPERLIPIDAEMIA 99 0.0083
676 ESCHERICHIA INFECTION 68 0.0083
677 WRIST FRACTURE 99 0.0083
678 GASTRITIS 217 0.0082
679 SLEEP APNOEA SYNDROME 157 0.0082
680 MULTI-ORGAN FAILURE 142 0.0082
681 LOSS OF CONSCIOUSNESS 1050 0.0082
682 BLOOD PRESSURE ABNORMAL 162 0.0081
683 ANAPHYLACTIC SHOCK 210 0.0081
684 HEART RATE IRREGULAR 184 0.0081
685 MUSCLE ATROPHY 103 0.0081
686 THYROID CANCER 97 0.0081
687 PRURITUS GENERALISED 174 0.0080
688 NEUROPATHY PERIPHERAL 764 0.0080
689 DIARRHOEA HAEMORRHAGIC 75 0.0080
690 INTESTINAL PERFORATION 90 0.0080
691 THROMBOSIS 644 0.0080
692 CYTOPENIA 98 0.0080
693 GINGIVAL BLEEDING 109 0.0080
694 KNEE OPERATION 78 0.0079
695 FOETAL EXPOSURE DURING PREGNANCY 642 0.0079
696 SKIN SWELLING 68 0.0078
697 OVARIAN CANCER 72 0.0078
698 INJECTION SITE RASH 239 0.0078
699 HEPATOCELLULAR INJURY 110 0.0078
700 INJECTION SITE BRUISING 616 0.0077
701 SURGERY 451 0.0077
702 THERAPY PARTIAL RESPONDER 120 0.0077
703 HYPOKALAEMIA 355 0.0077
704 HEART RATE INCREASED 761 0.0077
705 RENAL FAILURE 1017 0.0077
706 DEVICE RELATED INFECTION 117 0.0076
707 FLANK PAIN 71 0.0076
708 ANXIETY 2147 0.0075
709 ARTERIOSCLEROSIS 71 0.0075
710 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 393 0.0075
711 OESOPHAGITIS 82 0.0075
712 PHOTOPHOBIA 141 0.0075
713 COLITIS 283 0.0075
714 ACUTE HEPATIC FAILURE 102 0.0075
715 GENERALISED OEDEMA 92 0.0074
716 POOR QUALITY SLEEP 159 0.0074
717 PNEUMOTHORAX 117 0.0074
718 DISEASE RECURRENCE 350 0.0074
719 ACUTE RESPIRATORY DISTRESS SYNDROME 130 0.0073
720 DYSPNOEA EXERTIONAL 276 0.0073
721 TEMPERATURE INTOLERANCE 75 0.0073
722 PRODUCT QUALITY ISSUE 976 0.0072
723 TACHYCARDIA 637 0.0072
724 INFLUENZA LIKE ILLNESS 590 0.0072
725 COAGULOPATHY 119 0.0071
726 NEUTROPHIL COUNT INCREASED 73 0.0071
727 EYE INFLAMMATION 68 0.0071
728 HAEMORRHOIDS 139 0.0071
729 APHONIA 98 0.0070
730 INJECTION SITE URTICARIA 170 0.0069
731 ACTIVITIES OF DAILY LIVING IMPAIRED 137 0.0069
732 OSTEONECROSIS OF JAW 171 0.0069
733 CHOLECYSTECTOMY 78 0.0068
734 PULMONARY HYPERTENSION 142 0.0068
735 JAUNDICE 183 0.0068
736 HEPATIC FAILURE 204 0.0068
737 SKIN CANCER 145 0.0067
738 HEPATOMEGALY 66 0.0067
739 CORONARY ARTERY OCCLUSION 92 0.0067
740 ANGINA PECTORIS 192 0.0067
741 EPISTAXIS 500 0.0067
742 TREATMENT NONCOMPLIANCE 365 0.0067
743 SINUS DISORDER 132 0.0067
744 BLOOD POTASSIUM INCREASED 108 0.0066
745 INJECTION SITE EXTRAVASATION 82 0.0066
746 SPLENOMEGALY 77 0.0066
747 MACULAR DEGENERATION 78 0.0065
748 PETECHIAE 68 0.0065
749 CARDIOMYOPATHY 96 0.0065
750 CHOLECYSTITIS 77 0.0065
751 BONE MARROW FAILURE 131 0.0064
752 CORONARY ARTERY DISEASE 194 0.0064
753 OSTEONECROSIS 210 0.0064
754 MYELODYSPLASTIC SYNDROME 92 0.0064
755 ANAEMIA 1210 0.0063
756 SKIN HAEMORRHAGE 94 0.0063
757 VERTIGO 385 0.0063
758 GOUT 113 0.0063
759 SKIN FISSURES 123 0.0063
760 PROCEDURAL PAIN 174 0.0063
761 POST PROCEDURAL HAEMORRHAGE 73 0.0063
762 MYOCARDIAL ISCHAEMIA 71 0.0062
763 SWELLING FACE 406 0.0062
764 RENAL DISORDER 290 0.0062
765 THROAT IRRITATION 279 0.0062
766 ANOREXIA 80 0.0062
767 ABASIA 153 0.0062
768 ACUTE RESPIRATORY FAILURE 119 0.0062
769 LYMPHOPENIA 87 0.0061
770 INJECTION SITE PAIN 1877 0.0061
771 MITRAL VALVE INCOMPETENCE 69 0.0061
772 THROMBOCYTOPENIA 680 0.0061
773 INTENTIONAL DOSE OMISSION 173 0.0061
774 RASH ERYTHEMATOUS 290 0.0061
775 MIDDLE INSOMNIA 113 0.0060
776 BRONCHOSPASM 86 0.0060
777 HIP FRACTURE 193 0.0060
778 END STAGE RENAL DISEASE 109 0.0060
779 PERIPHERAL COLDNESS 82 0.0060
780 CHILLS 699 0.0060
781 FEELING ABNORMAL 1427 0.0059
782 ASPIRATION 65 0.0059
783 FEELING JITTERY 113 0.0059
784 SYNCOPE 593 0.0059
785 SNEEZING 132 0.0059
786 RESTLESS LEGS SYNDROME 107 0.0059
787 EOSINOPHILIA 103 0.0059
788 BLOOD POTASSIUM DECREASED 176 0.0058
789 MYOCARDIAL INFARCTION 1021 0.0058
790 PALPITATIONS 685 0.0058
791 UNEVALUABLE EVENT 441 0.0058
792 ATRIAL FIBRILLATION 565 0.0058
793 COVID-19 1007 0.0057
794 CARDIAC FAILURE 460 0.0057
795 CRYING 208 0.0057
796 MYALGIA 973 0.0057
797 ILLNESS 587 0.0057
798 CARDIOMEGALY 70 0.0057
799 BLOOD TRIGLYCERIDES INCREASED 100 0.0057
800 FEELING COLD 157 0.0056
801 ACUTE MYOCARDIAL INFARCTION 166 0.0056
802 PROTEINURIA 107 0.0056
803 CHOLESTASIS 108 0.0056
804 NERVOUS SYSTEM DISORDER 175 0.0056
805 BURNING SENSATION 390 0.0056
806 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1002 0.0056
807 THROAT TIGHTNESS 150 0.0055
808 ECZEMA 290 0.0055
809 HUNGER 77 0.0055
810 DYSPHONIA 323 0.0055
811 HYPERHIDROSIS 710 0.0055
812 SKIN DISCOLOURATION 253 0.0055
813 RESPIRATORY FAILURE 398 0.0055
814 PULMONARY OEDEMA 244 0.0054
815 SWOLLEN TONGUE 170 0.0054
816 BLINDNESS UNILATERAL 76 0.0054
817 LEUKOCYTOSIS 97 0.0054
818 INCORRECT PRODUCT ADMINISTRATION DURATION 116 0.0053
819 RASH MACULAR 186 0.0053
820 NEUTROPENIA 716 0.0053
821 PERICARDIAL EFFUSION 121 0.0052
822 CARDIAC FAILURE CONGESTIVE 411 0.0051
823 TOOTH LOSS 105 0.0051
824 DIABETES MELLITUS INADEQUATE CONTROL 89 0.0050
825 CHEST DISCOMFORT 514 0.0050
826 BREAST CANCER 467 0.0050
827 HAEMATEMESIS 127 0.0050
828 SARS-COV-2 TEST POSITIVE 66 0.0050
829 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 128 0.0050
830 HOSPITALISATION 762 0.0050
831 TRANSIENT ISCHAEMIC ATTACK 167 0.0049
832 BLOOD BILIRUBIN INCREASED 133 0.0049
833 BONE LOSS 74 0.0049
834 HAEMATOCHEZIA 271 0.0049
835 ANGIOEDEMA 217 0.0049
836 CARDIOVASCULAR DISORDER 123 0.0048
837 RASH GENERALISED 124 0.0048
838 ARRHYTHMIA 226 0.0048
839 BLOOD UREA INCREASED 79 0.0047
840 HYPOAESTHESIA ORAL 71 0.0047
841 COLD SWEAT 83 0.0047
842 MULTIPLE ORGAN DYSFUNCTION SYNDROME 133 0.0047
843 HAEMOPTYSIS 130 0.0047
844 LYMPHOCYTE COUNT DECREASED 82 0.0046
845 PRODUCT DOSE OMISSION IN ERROR 131 0.0046
846 PELVIC PAIN 84 0.0046
847 TOXIC EPIDERMAL NECROLYSIS 70 0.0046
848 LIP SWELLING 152 0.0046
849 PULMONARY ARTERIAL HYPERTENSION 66 0.0046
850 INJECTION SITE HAEMORRHAGE 362 0.0045
851 BONE PAIN 265 0.0045
852 RASH PAPULAR 101 0.0045
853 UPPER GASTROINTESTINAL HAEMORRHAGE 75 0.0045
854 PLATELET COUNT DECREASED 473 0.0044
855 POLLAKIURIA 183 0.0044
856 BLOOD PRESSURE DECREASED 291 0.0044
857 DRUG INTERACTION 693 0.0044
858 NERVOUSNESS 227 0.0043
859 DYSPHAGIA 411 0.0043
860 MOOD SWINGS 138 0.0043
861 PRODUCT PRESCRIBING ERROR 103 0.0043
862 HOT FLUSH 324 0.0043
863 DEPRESSED MOOD 227 0.0043
864 DYSURIA 158 0.0043
865 CARDIAC DISORDER 401 0.0043
866 TINNITUS 196 0.0043
867 LUNG NEOPLASM MALIGNANT 175 0.0043
868 TUBULOINTERSTITIAL NEPHRITIS 79 0.0042
869 SKIN EXFOLIATION 354 0.0042
870 HYPOXIA 147 0.0042
871 HYPOTENSION 830 0.0041
872 HEMIPARESIS 70 0.0041
873 SPEECH DISORDER 216 0.0041
874 HAEMATOMA 106 0.0041
875 AGRANULOCYTOSIS 76 0.0041
876 ABORTION SPONTANEOUS 163 0.0041
877 AGEUSIA 101 0.0040
878 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 222 0.0040
879 COMA 192 0.0040
880 EYE PAIN 226 0.0040
881 PALLOR 109 0.0040
882 RENAL FAILURE ACUTE 169 0.0040
883 GASTROINTESTINAL HAEMORRHAGE 332 0.0040
884 HYPOACUSIS 168 0.0039
885 INTENTIONAL PRODUCT MISUSE 341 0.0039
886 BLINDNESS 157 0.0038
887 URINARY INCONTINENCE 113 0.0038
888 THIRST 68 0.0038
889 SOMNOLENCE 754 0.0037
890 DEHYDRATION 497 0.0037
891 ENCEPHALOPATHY 90 0.0037
892 EYE SWELLING 136 0.0037
893 FAECES DISCOLOURED 79 0.0036
894 NEEDLE ISSUE 104 0.0036
895 HEAD INJURY 113 0.0036
896 DEVICE MALFUNCTION 250 0.0036
897 DIPLOPIA 92 0.0035
898 EYE PRURITUS 119 0.0035
899 BALANCE DISORDER 306 0.0035
900 INTESTINAL OBSTRUCTION 133 0.0035
901 SHOCK 81 0.0035
902 HAEMATURIA 119 0.0035
903 LETHARGY 198 0.0034
904 STEVENS-JOHNSON SYNDROME 76 0.0034
905 CEREBROVASCULAR ACCIDENT 578 0.0034
906 PERITONITIS 70 0.0034
907 ACUTE KIDNEY INJURY 513 0.0033
908 ASCITES 98 0.0033
909 CHROMATURIA 75 0.0033
910 CEREBRAL INFARCTION 81 0.0033
911 PAIN OF SKIN 89 0.0033
912 BLOOD CREATINE PHOSPHOKINASE INCREASED 95 0.0033
913 OCULAR HYPERAEMIA 155 0.0033
914 FEAR 87 0.0032
915 PSYCHOTIC DISORDER 95 0.0032
916 INTERNATIONAL NORMALISED RATIO INCREASED 91 0.0032
917 MENTAL DISORDER 138 0.0032
918 THERAPY INTERRUPTED 226 0.0032
919 INJECTION SITE MASS 116 0.0031
920 PRODUCT DISPENSING ERROR 68 0.0031
921 HYPOGLYCAEMIA 150 0.0031
922 EYE IRRITATION 178 0.0031
923 MOOD ALTERED 84 0.0031
924 PRESYNCOPE 74 0.0030
925 TOXICITY TO VARIOUS AGENTS 512 0.0030
926 PRODUCT DOSE OMISSION 197 0.0030
927 MELAENA 66 0.0030
928 ACNE 226 0.0030
929 HAEMORRHAGE 311 0.0030
930 RESPIRATORY DISTRESS 82 0.0030
931 SUICIDAL IDEATION 270 0.0029
932 VISION BLURRED 404 0.0029
933 HYPERSOMNIA 84 0.0029
934 PREMATURE BABY 88 0.0029
935 FLATULENCE 163 0.0029
936 INCORRECT DOSE ADMINISTERED 652 0.0029
937 TREMOR 474 0.0029
938 MYELOSUPPRESSION 102 0.0028
939 ABDOMINAL PAIN LOWER 71 0.0028
940 PRODUCT DOSE OMISSION ISSUE 803 0.0027
941 DISORIENTATION 108 0.0027
942 DRY SKIN 358 0.0027
943 DYSGEUSIA 197 0.0026
944 VISUAL ACUITY REDUCED 88 0.0026
945 DISEASE PROGRESSION 310 0.0026
946 THERAPEUTIC RESPONSE UNEXPECTED 117 0.0026
947 APHASIA 78 0.0026
948 FLUSHING 261 0.0026
949 CHRONIC KIDNEY DISEASE 195 0.0026
950 OVERDOSE 553 0.0026
951 ACCIDENTAL OVERDOSE 92 0.0025
952 DRUG DOSE OMISSION 413 0.0025
953 HYPONATRAEMIA 140 0.0025
954 CONSTIPATION 538 0.0025
955 WRONG TECHNIQUE IN DRUG USAGE PROCESS 89 0.0024
956 CARDIO-RESPIRATORY ARREST 102 0.0024
957 DYSARTHRIA 91 0.0024
958 MULTIPLE SCLEROSIS 113 0.0024
959 DEVICE ISSUE 209 0.0023
960 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 165 0.0023
961 LACRIMATION INCREASED 69 0.0023
962 NEUTROPHIL COUNT DECREASED 93 0.0023
963 HYPERGLYCAEMIA 81 0.0022
964 NO ADVERSE EVENT 402 0.0022
965 SEIZURE 256 0.0022
966 RHABDOMYOLYSIS 92 0.0022
967 PANIC ATTACK 79 0.0022
968 THERAPY CESSATION 109 0.0021
969 URINARY RETENTION 69 0.0021
970 BLOOD GLUCOSE INCREASED 385 0.0020
971 CARDIAC ARREST 156 0.0019
972 VAGINAL HAEMORRHAGE 81 0.0019
973 COGNITIVE DISORDER 87 0.0019
974 DEVICE BREAKAGE 75 0.0018
975 SKIN BURNING SENSATION 127 0.0018
976 DYSKINESIA 72 0.0018
977 DRUG DEPENDENCE 278 0.0017
978 DEPRESSED LEVEL OF CONSCIOUSNESS 67 0.0017
979 CONVULSION 92 0.0016
980 BLOOD GLUCOSE DECREASED 77 0.0016
981 IRRITABILITY 95 0.0016
982 DISTURBANCE IN ATTENTION 85 0.0016
983 DEATH 1330 0.0015
984 ACCIDENTAL EXPOSURE TO PRODUCT 158 0.0015
985 HALLUCINATION 113 0.0015
986 PRODUCT STORAGE ERROR 126 0.0014
987 AGITATION 104 0.0014
988 PROSTATE CANCER 106 0.0013
989 EMOTIONAL DISTRESS 151 0.0012
990 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 249 0.0012